Gotham Asset Management’s AMTD IDEA Group American Depositary Shares, each representing three hundred sixty (360) Class A Ordinary Shares AMTD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-1,201
Closed -$1.7M – 1690
2025
Q2
$1.7M Sell
1,201
-642
-35% -$39.2K 0.01% 977
2025
Q1
$2.01M Buy
1,843
+1,076
+140% +$68.8K 0.02% 802
2024
Q4
$967K Sell
767
-930
-55% -$71.1K 0.01% 925
2024
Q3
$3.28M Buy
+1,697
New +$143K 0.03% 598

Other funds holding AMTD

Gotham Asset Management's AMTD Position: Q3 2025 in Review

Gotham Asset Management sold out of AMTD IDEA Group American Depositary Shares, each representing three hundred sixty (360) Class A Ordinary Shares (AMTD) in Q3 2025, closing a stake of 1,201 shares — an estimated $1.7M sold.

Gotham Asset Management first reported a position in AMTD in Q3 2024 and held it in 4 quarters. The position peaked at $3.28M in Q3 2024. 8 funds tracked by Wall St. Rank hold AMTD as of Q3 2025.

  • Gotham Asset Management reported no remaining AMTD IDEA Group American Depositary Shares, each representing three hundred sixty (360) Class A Ordinary Shares position as of Q3 2025 after selling out during the quarter.
  • Gotham Asset Management sold 1,201 AMTD IDEA Group American Depositary Shares, each representing three hundred sixty (360) Class A Ordinary Shares shares in Q3 2025, an estimated $1.7M.
  • Gotham Asset Management first reported a position in AMTD IDEA Group American Depositary Shares, each representing three hundred sixty (360) Class A Ordinary Shares in Q3 2024 and held it in 4 quarters.
  • Gotham Asset Management's AMTD IDEA Group American Depositary Shares, each representing three hundred sixty (360) Class A Ordinary Shares position peaked at $3.28M in Q3 2024.
  • 8 funds tracked by Wall St. Rank held AMTD IDEA Group American Depositary Shares, each representing three hundred sixty (360) Class A Ordinary Shares as of Q3 2025.

Based on Gotham Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.